ACCC association of cancer care centers
Join/Renew
Login
Join/Renew
Login
Education & Resources
ACCC eXchange LogInSponsored Education from ACCC Corporate PartnersACCC eLearning LogInPresentations & Abstracts
Publications
Oncology IssuesPatient Assistance & Reimbursement GuideTrending Now in Cancer CareBusiness Case Studies for Hiring New Staff
Events
2026 ACCC Leadership SummitAnnual Meeting & Cancer Center Business SummitCapitol Hill DayNational Oncology ConferenceOncology Reimbursement MeetingsOncology State Society Meetings
Policy & Advocacy
ACCC 2026 Policy PrioritiesLetters & StatementsAccess, Payment & Reimbursement ReformWhite Bagging & Brown BaggingAdvocacy ResourcesCancer Moonshot
Membership
Join | RenewWho We AreMembership Types & BenefitsCorporate MembersACCC Member Portal FAQMember Directory
Partners
Oncology State SocietiesPartner OrganizationsCME
News
News ReleasesAdvocacy News ReleasesOncology News
About ACCC
Timeline / 50th Anniversary2025 Impact ReportPresident's ThemeACCC Innovator AwardsACCC FellowsBoard of TrusteesACCC Senior Staff
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
Join/Renew
Login
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
    • Education & Resources
    • Publications
    • Events
    • Policy & Advocacy
    • Membership
    • Partners
    • News
    • About ACCC
ACCC association of cancer care centers
5425 Wisconsin Ave #600, Chevy Chase, MD 20815
Tel: 301.984.9496 Email Us
Contact UsVolunteers
Advertise
Career Center
Terms and Conditions
Privacy Policy
ACCC Rebranding
Copyright © 2026 Association of Cancer Care Centers. All Rights Reserved.
HomeACCCBuzz Blog

Citrus Oncology: Revolutionizing Cancer Care by Addressing Side Effects

June 13, 2024
By Afreen Shariff, MD, MBBS

Citrus Oncology is the first virtual multi-specialty care platform designed to help patients manage the side effects of cancer treatment.

Citrus Oncology: Revolutionizing Cancer Care by Addressing Side Effects

Eighty-nine days, that is the average wait time for a patient with cancer hoping to see a specialist who understands and can manage their side effects of treatment. Considering that cancer treatment is a balancing act, with results often accompanied by debilitating side effects, that is unacceptable. As an endocrinologist, I have witnessed firsthand the life-threatening side effects that patients with cancer endure, such as diabetes, adrenal insufficiency, colitis, pneumonitis, and more. I have counseled and comforted patients and families about continuing effective cancer treatment despite side effects and supported oncologists in their treatment decisions. I have seen the devastating effects delays in addressing treatment side effects can have. To reduce poor outcomes like hospitalizations, patients need to be given support for managing their side effects as soon as they develop—not weeks to months later.

Recognizing this unmet need, Citrus Oncology—the first virtual multi-specialty care platform designed to help patients manage the side effects of cancer treatment—was born from the vision of my co-founder Aabid Shariff, PhD, and I, who sought to transform cancer care by providing comprehensive support for managing treatment-related complications.

Shariff_Afreen-300x300f

Driven by a deep commitment to improving access and patient outcomes, we embarked on a mission to create a platform that would empower patients and health care providers alike to manage side effects urgently—irrespective of location and specialty.

A Holistic Approach to Cancer Care

Citrus Oncology brings together a multidisciplinary team of specialists, including onco-endocrinologists, onco-nephrologists, onco-dermatologists, rheum-oncologists, cardio-oncologists, and more to address the complex challenges faced by patients with cancer. By integrating expertise from various medical domains, the platform offers a comprehensive solution for managing the intricate side effects of cancer treatment and supports the chronic pre-existing conditions of patients with cancer.

cancer-care-975x652

Empowering Patients and Providers

At the core of Citrus Oncology lies a dedication to patient empowerment and oncologist support. Patients can get access to care through 3 tiers of service, including asynchronous consultations and video visits. This innovative approach allows patients to take an active role in their care while leveraging the collective knowledge of leading specialists. Moreover, Citrus Oncology recognizes the importance of collaboration within the medical community. Through peer-to-peer electronic-consults, the platform enables oncologists to seek guidance from Citrus Oncology's specialists, fostering a collaborative environment that enhances patient care. In the future, Citrus Oncology will include insurance pay in addition to the current cash pay model to support patients and oncology practices.

Embracing Innovation and Value-Based Care

Citrus Oncology is at the forefront of innovation, using modern data-driven technologies, supporting clinical trials, and exploring value-based contracts with payers. For pharmaceutical companies and Trial sites, Citrus Oncology can enhance clinical trials by providing proactive management of treatment side effects, improving patient outcomes, and trial success rates. For payers, Citrus Oncology can help by offering value-based contracts that align incentives with improved patient outcomes and cost-effectiveness in managing cancer treatment side effects.

As Citrus Oncology continues to grow, its mission remains steadfast: to provide comprehensive, personalized care that addresses the multifaceted challenges faced by patients with cancer. With a focus on innovation, empowerment, and collaboration—with a nationwide network of care providers—Citrus Oncology is poised to revolutionize the cancer care landscape, offering hope and support to those navigating the complexities of this disease.

We are currently offering services in Florida for endocrinology, nephrology and dermatology, for expert opinions in the management of treatment side effects. For more information and to follow our launch in other States, visit our website. Visit our partners page for a detailed description of our services. If you are a patient, please reach out to us for more information so we can find a way to help you. If you are an oncology provider, or a group running clinical trials, we look forward to working with you and your patients.

Afreen Shariff, MD, MBBS, is an endocrinologist, thought leader, and expert in the field of managing hormone-related side effects in patients with cancer. Dr. Shariff is a trailblazer in the field of Endocrine Oncology and is recognized internationally for her passion to improve access and quality of care for patients with cancer. She is also a member of the Association of Cancer Care Centers (ACCC) Board of Trustees.

Related Content

Addressing the In-Between: AYAs and Multifaceted Cancer TreatmentACCCBuzz Blog

Addressing the In-Between: AYAs and Multifaceted Cancer Treatment

Jenna Pierson

September 30, 2026

From Diagnosis to Survivorship: Understanding AML and CLL From End to EndACCCBuzz Blog

From Diagnosis to Survivorship: Understanding AML and CLL From End to End

Rachel Radwan

September 28, 2026

Upcoming Events

ACCC 43rd National Oncology Conference

ACCC 43rd National Oncology Conference

In Person October 21, 2026 at 8:00 AM EDT450 Summer St, Boston, MA 02210, USAOmni Boston Hotel at the Seaport, Boston
Register Now!
ACCC Oncology Reimbursement Meeting | Reno

ACCC Oncology Reimbursement Meeting | Reno

In Person November 4, 2026 at 8:00 AM EST255 North Virginia Street, Reno, NV, USAWhitney Peak Hotel Reno, Tapestry Collection by Hilton,
Register Now!
ACCC Oncology Reimbursement Meeting | Providence

ACCC Oncology Reimbursement Meeting | Providence

In Person November 10, 2026 at 8:00 AM EST5 Avenue of the Arts, Providence, RI, USARenaissance Providence Downtown Hotel,
Register Now!
ACCC Leadership Summit

ACCC Leadership Summit

In Person April 22, 2027 at 8:00 AM EDTInterContinental the Willard Washington D.C. by IHG, 1401 Pennsylvania Ave NW, Washington, DC 20004, USAWillard Intercontinental,
Register Now!
Advertisement
Advertisement

Trending Now on
ACCCBuzz Blog

Addressing the In-Between: AYAs and Multifaceted Cancer Treatment

Addressing the In-Between: AYAs and Multifaceted Cancer Treatment

From mental health concerns to fertility preservation, adolescents and young adults with cancer require a specialized approach to treatment and survivorship care. In honor of Childhood Cancer Awareness Month, ACCC highlights a pivotal program from the University of North Carolina Lineberger Comprehensive Cancer Center and resources that meet the critical needs of these patients.

From Diagnosis to Survivorship: Understanding AML and CLL From End to End

From Diagnosis to Survivorship: Understanding AML and CLL From End to End

In recognition of Leukemia and Lymphoma Awareness Month, ACCC compiled a group of resources to help care teams navigate two of the most commonly diagnosed adult leukemias: acute myeloid leukemia and chronic lymphocytic leukemia.

Gynecologic Cancer Awareness Month: Expanding Access and Improving Outcomes
ACCCBuzz Blog

Gynecologic Cancer Awareness Month: Expanding Access and Improving Outcomes

Jenna Pierson; Gabrielle Stearns

September 25, 2026

ACCC’s Comments on the 2026 CMS Interim Final RuleACCCBuzz Blog

ACCC’s Comments on the 2026 CMS Interim Final Rule

Rachel Radwan

September 24, 2026

Decentralized Clinical Trials in Community Oncology: Advancing Access Requires More Than TechnologyACCCBuzz Blog

Decentralized Clinical Trials in Community Oncology: Advancing Access Requires More Than Technology

September 10, 2026

Highlights From Volume 41, Number 4 Oncology IssuesACCCBuzz Blog

Highlights From Volume 41, Number 4 Oncology Issues

Gabrielle Stearns

August 20, 2026

Transforming Access to Care Through Pre-Intake NavigationACCCBuzz Blog

Transforming Access to Care Through Pre-Intake Navigation

Rachel Radwan

August 6, 2026

An APP-Led Outpatient Bispecific Antibody ClinicACCCBuzz Blog

An APP-Led Outpatient Bispecific Antibody Clinic

Rachel Radwan

August 4, 2026

Gynecologic Cancer Awareness Month: Expanding Access and Improving Outcomes

Gynecologic Cancer Awareness Month: Expanding Access and Improving Outcomes

An at-home option for cervical cancer screening breaks down barriers to care and offers the same level of precision as screening in the clinic.

ACCC’s Comments on the 2026 CMS Interim Final Rule

ACCC’s Comments on the 2026 CMS Interim Final Rule

On June 1, 2026, CMS published its interim final rule (IFR), Medicaid Program; Community Engagement Requirement for Certain Individuals in the Federal Register, followed by a public comment period, during which time ACCC submitted a comment letter requesting amendments to the IFR.

View All ACCCBuzz Blogs

Recently Heard on
CANCER BUZZ Podcast

Bringing CAR T-Cell Therapy to the Community Setting - Mini Podcast [Ep. 242]

Embedding Local Expertise in Rural Cancer Prevention - Podcast [Ep. 241]

From Reactive to Proactive: Improving Access to Cancer Care Through Pre-Intake Navigation - [Podcast] Ep. 240

Real-World Oncology Decentralized Trials - [Video Podcast] Ep. 66

View All Podcasts

Latest from Oncology Issues

August 2026
August 2026
June 2026
April 2026
February 2026
December 2025
View All Oncology Issues

Join the Conversation

ACCC eXchange Digital Banner
Login